{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:17:02Z","timestamp":1790223422087,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jid.2016.08.016","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T15:13:53Z","timestamp":1473434033000},"page":"257-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["TIGIT and Helios Are Highly Expressed on CD4+ T Cells in S\u00e9zary Syndrome Patients"],"prefix":"10.1016","volume":"137","author":[{"given":"Neha","family":"Jariwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernice","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V.","family":"Kossenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon K.","family":"Oetjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Showe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wysocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2016.08.016_bib1","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.4049\/jimmunol.1401803","article-title":"Coexpression of TIGIT and FCRL3 identifies\u00a0Helios+ human memory regulatory T cells","volume":"194","author":"Bin Dhuban","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.08.016_bib2","doi-asserted-by":"crossref","first-page":"e1005349","DOI":"10.1371\/journal.ppat.1005349","article-title":"TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection","volume":"12","author":"Chew","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jid.2016.08.016_bib3","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1038\/jid.2009.175","article-title":"FOXP3+CD25- tumor cells with regulatory function in Sezary syndrome","volume":"129","author":"Heid","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.08.016_bib4","doi-asserted-by":"crossref","first-page":"e1036214","DOI":"10.1080\/2162402X.2015.1036214","article-title":"The checkpoint inhibitor TIGIT limits antitumor and antiviral CD8 T cell responses","volume":"4","author":"Johnston","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jid.2016.08.016_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2016.08.016_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/QAI.0000000000001000","article-title":"FOXP3+Helios+ regulatory T cells, immune activation and advancing disease in HIV infected children","volume":"72","author":"Khaitan","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jid.2016.08.016_bib7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.08.016_bib8","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.4049\/jimmunol.1501591","article-title":"Panoutsakopoulou V TIGIT enhances antigen-specific Th2 recall responses and allergic disease","volume":"196","author":"Kourepini","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.08.016_bib9","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1172\/JCI81187","article-title":"TIGIT predominantly regulates the immune response via regulatory T cells","volume":"125","author":"Kurtulus","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.08.016_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fimmu.2015.00418","article-title":"Beyond CTLA-4 and PD-1, the generation Z of negative checkpoint regulators","volume":"6","author":"Le Mercier","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2016.08.016_bib11","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3892\/ijo.2015.3196","article-title":"Clinical significance of expanded Foxp3(+) Helios(-) regulatory T cells in patients with non-small cell lung cancer","volume":"47","author":"Muto","year":"2015","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jid.2016.08.016_bib12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ccell.2014.11.016","article-title":"TIGIT and CD226: tipping the balance between costimulatory and coinhibitory molecules to augment the cancer immunotherapy toolkit","volume":"26","author":"Pauken","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2016.08.016_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4049\/jimmunol.1501704","article-title":"Helios controls a limited subset of regulatory T cell functions","volume":"196","author":"Sebastian","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.08.016_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/jid.2013.279","article-title":"CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sezary syndrome patients","volume":"134","author":"Wysocka","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.08.016_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00262-016-1799-4","article-title":"Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155","volume":"65","author":"Zhang","year":"2016","journal-title":"Cancer Immunol Immunother"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16323508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16323508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:15:45Z","timestamp":1601072145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X16323508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0022202X16323508"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2016.08.016","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TIGIT and Helios Are Highly Expressed on CD4+ T Cells in S\u00e9zary Syndrome Patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}